rs9788972
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The XM_047437096.1(NTN1):c.-63-5998G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.286 in 151,850 control chromosomes in the GnomAD database, including 6,336 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.29 ( 6336 hom., cov: 31)
Consequence
NTN1
XM_047437096.1 intron
XM_047437096.1 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.481
Publications
10 publications found
Genes affected
NTN1 (HGNC:8029): (netrin 1) Netrin is included in a family of laminin-related secreted proteins. The function of this gene has not yet been defined; however, netrin is thought to be involved in axon guidance and cell migration during development. Mutations and loss of expression of netrin suggest that variation in netrin may be involved in cancer development. [provided by RefSeq, Jul 2008]
NTN1 Gene-Disease associations (from GenCC):
- mirror movements 4Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- familial congenital mirror movementsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- multiple congenital anomalies/dysmorphic syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.396 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| NTN1 | XM_047437096.1 | c.-63-5998G>A | intron_variant | Intron 1 of 6 | XP_047293052.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|
Frequencies
GnomAD3 genomes AF: 0.286 AC: 43378AN: 151730Hom.: 6334 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
43378
AN:
151730
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.286 AC: 43411AN: 151850Hom.: 6336 Cov.: 31 AF XY: 0.291 AC XY: 21564AN XY: 74202 show subpopulations
GnomAD4 genome
AF:
AC:
43411
AN:
151850
Hom.:
Cov.:
31
AF XY:
AC XY:
21564
AN XY:
74202
show subpopulations
African (AFR)
AF:
AC:
10815
AN:
41402
American (AMR)
AF:
AC:
4846
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
AC:
1038
AN:
3470
East Asian (EAS)
AF:
AC:
1033
AN:
5152
South Asian (SAS)
AF:
AC:
1974
AN:
4796
European-Finnish (FIN)
AF:
AC:
3567
AN:
10526
Middle Eastern (MID)
AF:
AC:
86
AN:
292
European-Non Finnish (NFE)
AF:
AC:
19196
AN:
67942
Other (OTH)
AF:
AC:
571
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1552
3103
4655
6206
7758
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
440
880
1320
1760
2200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.